Home › Kanser sa Prostate › Ohio › Cincinnati
Pag-aaral pangklinika para sa Kanser sa Prostate sa Cincinnati, OH
19 pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Cincinnati (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Nagre-recruitPhase 3
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Nagre-recruitPhase 1
- Oncology Hematology Care Incorporated, Cincinnati
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- at 3 pa
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Nagre-recruitPhase 2
- Saint Elizabeth Healthcare Edgewood, Edgewood · 8 mi ang layo
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Nagre-recruitPhase 1
- University of Cincinnati Medical Center, Cincinnati
Real World Prostate Cancer Registry
Nagre-recruitObservasyonal na pag-aaral
- Cincinnati Cancer Advisors, Cincinnati
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Research Site 113, Cincinnati
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Nagre-recruitPhase 3
- Oncology Hematology Care Incorporated, Cincinnati
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
Nagre-recruitPhase 3
- Research Site, Cincinnati
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Nagre-recruitPhase 3
- Urology Group - Solaris Network, Cincinnati
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Nagre-recruitPhase 3
- TriState Urologic Services PSC Inc. dba The Urology Group, Cincinnati
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Nagre-recruitPhase 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi ang layo
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Nagre-recruitPhase 1
- Oncology Hematology Care Incorporated, Cincinnati
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Nagre-recruitPhase 2
- Solaris Health - The Urology Group, Cincinnati
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Nagre-recruitPhase 3
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- at 1 pa
Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)
Nagre-recruitObservasyonal na pag-aaral
- The University of Cinncinatti, Cincinnati
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Nagre-recruitPhase 2
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- at 1 pa
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Nagre-recruitPhase 3
- Oncology Hematology Care Inc-Kenwood, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Cincinnati
Pag-aaral para sa Kanser sa Prostate sa ibang lungsod
- New York City, NY101 pag-aaral
- Houston, TX73 pag-aaral
- Los Angeles, CA64 pag-aaral
- Boston, MA56 pag-aaral
- Seattle, WA45 pag-aaral
- St. Louis, MO45 pag-aaral
- Chicago, IL45 pag-aaral
- Baltimore, MD45 pag-aaral
- San Francisco, CA44 pag-aaral
- Philadelphia, PA41 pag-aaral
- Nashville, TN40 pag-aaral
- Washington, DC39 pag-aaral
Iba pang pag-aaral sa Cincinnati
- Non-Small Cell Lung Cancer31 pag-aaral
- Kanser (lahat ng uri)26 pag-aaral
- Kanser sa Suso24 pag-aaral
- Pagkabigo ng Puso22 pag-aaral
- Metastatic Cancer21 pag-aaral
- Colorectal Cancer20 pag-aaral
- Obesity20 pag-aaral
- Acute Myeloid Leukemia20 pag-aaral
- Kanser sa Ovary18 pag-aaral
- Kanser sa Baga18 pag-aaral
- Multiple Myeloma17 pag-aaral
- Sakit sa Puso at Ugat ng Dugo16 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.